These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Results of treatment of non-Hodgkin's lymphoma according to a standardized program (LSA2L2)]. Ochocka M; Newecka-Samól T; Ciepielewska D Pediatr Pol; 1981 Sep; 56(9):1071-7. PubMed ID: 7322676 [No Abstract] [Full Text] [Related]
25. cis-dichlorodiammineplatinum(II) with and without ICRF-159 in non-Hodgkin's lymphoma. Corder MP; Wiesenfeld M; Maguire LC; Leimert JT; Panther SK Cancer Treat Rep; 1980; 64(2-3):301-4. PubMed ID: 7190869 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma. Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350 [No Abstract] [Full Text] [Related]
28. [Current status of chemotherapy of non-Hodgkin's lymphoma in Japan and Western countries (author's transl)]. Sakano T Rinsho Hoshasen; 1979; 24(10):1227-39. PubMed ID: 502075 [No Abstract] [Full Text] [Related]
29. Nodular lymphoma. Prolongation of survival by complete remission. Diggs CH; Wiernik PH; Ostrow SS Cancer Clin Trials; 1981; 4(2):107-14. PubMed ID: 7249248 [TBL] [Abstract][Full Text] [Related]
31. [Possibilities and limits of polychemotherapy in hematology]. István L Orv Hetil; 1982 Nov; 123(47):2879-85. PubMed ID: 7177635 [No Abstract] [Full Text] [Related]
33. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397 [TBL] [Abstract][Full Text] [Related]
34. Advances in the therapy of non-Hodgkin's lymphoma. Eckhardt S Recent Results Cancer Res; 1979; 69():63-75. PubMed ID: 382310 [No Abstract] [Full Text] [Related]
35. Use of bortezomib in B-cell non-Hodgkin's lymphoma. Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071 [TBL] [Abstract][Full Text] [Related]